US10792651B2ActiveUtilityA1

Synthesis and characterization of Ru alkylidene complexes

67
Assignee: UMICORE AG & CO KGPriority: Oct 19, 2016Filed: Oct 17, 2017Granted: Oct 6, 2020
Est. expiryOct 19, 2036(~10.3 yrs left)· nominal 20-yr term from priority
C08G 2261/418C08G 61/08C07F 15/0046C07C 2601/10C07C 67/333B01J 2531/821B01J 2231/543B01J 31/2295B01J 31/2278B01J 31/2273B01J 31/2409B01J 31/188B01J 31/1875B01J 31/2208B01J 31/2265B01J 31/2404B01J 31/187B01J 31/2414B01J 31/181C07F 9/6533C07F 9/59B01J 31/1855Y02P20/52
67
PatentIndex Score
0
Cited by
10
References
8
Claims

Abstract

This invention relates generally to olefin metathesis catalyst compounds, to the preparation of such compounds, compositions comprising such compounds, methods of using such compounds, articles of manufacture comprising such compounds, and the use of such compounds in the metathesis of olefins and olefin compounds. The invention has utility in the fields of catalysts, organic synthesis, polymer chemistry, and industrial and fine chemicals industry.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. An olefin metathesis catalyst represented by Formula (I): 
       
         
           
           
               
               
           
         
         wherein:
 M is ruthenium or osmium; 
 X 1  and X 2  are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; 
 L 1  is a ligand represented by the structure of Formula (II), or is a N-Heterocyclic Carbene ligand represented by the structure of Formula (III): 
 
       
       
         
           
           
               
               
           
         
         
           R 1  is unsubstituted saturated N-heterocycle, substituted saturated N-heterocycle, —NH(C 1 -C 24  alkyl), —N(C 1 -C 24  alkyl) 2 , —NH(C 5 -C 24  aryl), —N(C 5 -C 24  aryl) 2 , —N(C 1 -C 24  alkyl)(C 5 -C 24  aryl) or —N[(C 1 -C 6  alkylene) (C 5 -C 24  aryl)] 2 ; 
           R 2  is unsubstituted (C 5 -C 24  aryl), substituted (C 5 -C 24  aryl), unsubstituted saturated N-heterocycle, substituted saturated N-heterocycle, —NH(C 1 -C 24  alkyl), —N(C 1 -C 24  alkyl) 2 , —NH(C 5 -C 24  aryl), —N(C 5 -C 24  aryl) 2 , —N(C 1 -C 24  alkyl)(C 5 -C 24  aryl) or —N[(C 1 -C 6  alkylene)(C 5 -C 24  aryl)] 2 ; 
           R 3  is unsubstituted (C 5 -C 24  aryl), substituted (C 5 -C 24  aryl), unsubstituted saturated N-heterocycle, or substituted saturated N-heterocycle; 
           Y is CR 4  or N; 
           R 4  is hydrogen, unsubstituted (C 1 -C 12  alkyl), or substituted (C 1 -C 12  alkyl); 
           R 5  and R 6  are independently hydrogen, unsubstituted (C 5 -C 24  aryl), or substituted (C 5 -C 24  aryl); 
           Q is a two-atom linkage represented by structures —[CR 7 R 8 ] s —[CR 9 R 10 ] t — or —[CR 11 ═CR 12 ]—; 
           R 7 , R 8 , R 9  and R 10  are independently hydrogen, unsubstituted (C 1 -C 24  alkyl), substituted (C 1 -C 24  alkyl), unsubstituted (C 5 -C 24  aryl), or substituted (C 5 -C 24  aryl); 
           R 11  and R 12  are independently hydrogen, unsubstituted (C 1 -C 24  alkyl), substituted (C 1 -C 24  alkyl), unsubstituted (C 5 -C 24  aryl), or substituted (C 5 -C 24  aryl); and 
           “s” and “t” are independently 1 or 2. 
         
       
     
     
       2. The olefin metathesis catalyst according to  claim 1 , represented by the structure of Formula (VI): 
       
         
           
           
               
               
           
         
         wherein:
 X 1  is Cl; 
 X 2  is Cl; 
 R 1  is morpholino, thiomorpholino, 1-methyl-piperazino, piperidino, N-acetyl-piperazino, di-benzyl-amino, N-ethylcarboxylate-piperazino, diethylamino, methyl-phenylamino, or di-iso-propylamino; 
 R 2  is phenyl, morpholino, thiomorpholino, 1-methyl-piperazino, piperidino, N-acetyl piperazino, di-benzyl-amino, N-ethylcarboxylate-piperazino, diethylamino, methyl-phenylamino, or di-iso-propylamino; and 
 R 3  is phenyl or morpholino. 
 
       
     
     
       3. The olefin metathesis catalyst according to  claim 2 , selected from: 
       
         
           
           
               
               
           
         
       
     
     
       4. The olefin metathesis catalyst according to  claim 1 , represented by the structure of Formula (VII): 
       
         
           
           
               
               
           
         
       
     
     
       5. The olefin metathesis catalyst according to  claim 4 , represented by the structure of Formula (VIII): 
       
         
           
           
               
               
           
         
         wherein:
 X 1  is Cl; 
 X 2  is Cl; 
 R 1  is morpholino, thiomorpholino, 1-methyl-piperazino, piperidino, N-acetyl-piperazino, di-benzyl-amino, N-ethylcarboxylate-piperazino, diethylamino, methyl-phenylamino, or di-iso-propylamino; 
 R 2  is phenyl, morpholino, thiomorpholino, 1-methyl-piperazino, piperidino, N-acetyl-piperazino, di-benzyl-amino, N-ethylcarboxylate-piperazino, diethylamino, methyl-phenylamino, or di-iso-propylamino; 
 R 3  is phenyl or morpholino; and 
 R 5  and R 6  are independently 2,4,6-trimethyl-phenyl, 2,6-di-iso-propylphenyl, 2-iso-propylphenyl or 2-methyl-6-iso-propylphenyl; 
 Q is a two-atom linkage represented by structure —[CR 7 R 8 ] s —[CR 9 R 10 ] t —; 
 R 7 , R 8 , R 9  and R 10  are independently hydrogen; and 
 “s” and “t” are independently 1. 
 
       
     
     
       6. The olefin metathesis catalyst according to  claim 5 , selected from: 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
     
     
       7. A method of synthesizing an olefin metathesis catalyst represented by the structure of Formula (A): 
       
         
           
           
               
               
           
         
         the method comprising contacting an olefin metathesis catalyst represented by the structure of Formula (VIII): 
       
       
         
           
           
               
               
           
         
         with a PR d R e OR f  ligand at room temperature in an inert solvent, wherein:
 X 1  and X 2  are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; 
 R 1  is unsubstituted saturated N-heterocycle, substituted saturated N-heterocycle, —NH(C 1 -C 24  alkyl), —N(C 1 -C 24  alkyl) 2 , —NH(C 5 -C 24  aryl), —N(C 5 -C 24  aryl) 2 , —N(C 1 -C 24  alkyl)(C 5 -C 24  aryl) or —N[(C 1 -C 6  alkylene)(C 5 -C 24  aryl)] 2 ; 
 R 2  is unsubstituted (C 5 -C 24  aryl), substituted (C 5 -C 24  aryl), unsubstituted saturated N-heterocycle, substituted saturated N-heterocycle, —NH(C 1 -C 24  alkyl), —N(C 1 -C 24  alkyl) 2 , —NH(C 5 -C 24  aryl), —N(C 5 -C 24  aryl) 2 , —N(C 1 -C 24  alkyl)(C 5 -C 24  aryl) or —N[(C 1 -C 6  alkylene)(C 5 -C 24  aryl)] 2 ; 
 R 3  is unsubstituted (C 5 -C 24  aryl), substituted (C 5 -C 24  aryl), unsubstituted saturated N-heterocycle or substituted saturated N-heterocycle; 
 R 5  and R 6  are independently hydrogen, unsubstituted C 5 -C 24  aryl, or substituted C 5 -C 24  aryl; generally R 5  and R 6  are independently substituted C 5 -C 24  aryl with one to three unsubstituted (C 1 -C 6  alkyl) groups or substituted (C 1 -C 6  alkyl) groups; 
 R d  is unsubstituted C 1 -C 10  alkyl, substituted C 1 -C 10  alkyl, substituted C 6 -C 10  aryl, unsubstituted C 6 -C 10  aryl, substituted C 3 -C 8  cycloalkyl or unsubstituted C 3 -C 8  cycloalkyl; 
 R e  is unsubstituted C 1 -C 10  alkyl, substituted C 1 -C 10  alkyl, substituted C 6 -C 10  aryl, unsubstituted C 6 -C 10  aryl, substituted C 3 -C 8  cycloalkyl or unsubstituted C 3 -C 8  cycloalkyl; and 
 R f  is unsubstituted C 1 -C 10  alkyl, substituted C 1 -C 10  alkyl, substituted C 6 -C 10  aryl, unsubstituted C 6 -C 10  aryl, substituted C 3 -C 8  cycloalkyl or unsubstituted C 3 -C 8  cycloalkyl. 
 
       
     
     
       8. The method according to  claim 7 , wherein:
 X 1  is Cl; 
 X 2  is Cl; 
 R 1  is morpholino, thiomorpholino, 1-methyl-piperazino, piperidino, N-acetyl-piperazino, di-benzyl-amino, N-ethylcarboxylate-piperazino, diethylamino, methyl-phenylamino, or di-iso-propylamino; 
 R 2  is phenyl, morpholino, thiomorpholino, 1-methyl-piperazino, piperidino, N-acetyl-piperazino, di-benzyl-amino, N-ethylcarboxylate-piperazino, diethylamino, methyl-phenylamino, or di-iso-propylamino; and
 R 3  is phenyl or morpholino 
 R 5  is 2,4,6-trimethylphenyl; 
 R 6  is 2,4,6-trimethylphenyl; 
 R d  is phenyl; 
 R e  is phenyl; and 
 R f  is phenyl, methyl, p-(OMe)phenyl, or iso-propyl.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.